Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1058

1.

Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States.

Gans HA, Yasukawa LL, Alderson A, Rinki M, DeHovitz R, Beeler J, Audet S, Maldonado Y, Arvin AM.

J Infect Dis. 2004 Jul 1;190(1):83-90. Epub 2004 May 26.

PMID:
15195246
2.

Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months.

Gans H, Yasukawa L, Rinki M, DeHovitz R, Forghani B, Beeler J, Audet S, Maldonado Y, Arvin AM.

J Infect Dis. 2001 Oct 1;184(7):817-26. Epub 2001 Aug 22.

PMID:
11528592
3.

Age-dependent differences in IgG isotype and avidity induced by measles vaccine received during the first year of life.

Nair N, Gans H, Lew-Yasukawa L, Long-Wagar AC, Arvin A, Griffin DE.

J Infect Dis. 2007 Nov 1;196(9):1339-45. Epub 2007 Oct 2.

PMID:
17922398
4.

Seroconversion after measles vaccination at nine and fifteen months of age.

Işik N, Uzel N, Gökçay G, Kiliç A, Yilmaz G, Sadikoğlu B, Diri S.

Pediatr Infect Dis J. 2003 Aug;22(8):691-5.

PMID:
12913768
7.

Open randomized trial comparing the immunogenicity and safety of a new measles-mumps-rubella vaccine and a licensed vaccine in 12- to 24-month-old children.

Feiterna-Sperling C, Brönnimann R, Tischer A, Stettler P, Durrer P, Gaedicke G.

Pediatr Infect Dis J. 2005 Dec;24(12):1083-8.

PMID:
16371870
8.

Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age.

Redd SC, King GE, Heath JL, Forghani B, Bellini WJ, Markowitz LE.

J Infect Dis. 2004 May 1;189 Suppl 1:S116-22.

PMID:
15106100
9.

Measles and mumps vaccination as a model to investigate the developing immune system: passive and active immunity during the first year of life.

Gans H, DeHovitz R, Forghani B, Beeler J, Maldonado Y, Arvin AM.

Vaccine. 2003 Jul 28;21(24):3398-405. Review.

PMID:
12850348
10.

Humoral and cellular immune response after measles vaccination in Taiwan.

Huang CL, Yang YH, Wang LC, Lin YT, Tsai YY, Chiang BL.

J Microbiol Immunol Infect. 2005 Jun;38(3):169-75.

PMID:
15986066
11.

Measles vaccine immunogenicity and antibody persistence in 12 vs 15-month old infants.

Johnson CE, Darbari A, Darbari DS, Nalin D, Whitwell J, Chui LW, Cleves MA, Kumar ML.

Vaccine. 2000 May 8;18(22):2411-5.

PMID:
10738098
12.
13.
14.

Cellular and humoral immune responses to measles in immune adults re-immunized with measles vaccine.

Wong-Chew RM, Beeler JA, Audet S, Santos JI.

J Med Virol. 2003 Jun;70(2):276-80.

PMID:
12696117
15.

Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years.

Johnson CE, Kumar ML, Whitwell JK, Staehle BO, Rome LP, Dinakar C, Hurni W, Nalin DR.

Pediatr Infect Dis J. 1996 Aug;15(8):687-92.

PMID:
8858673
16.

Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month-old Mexican children.

Wong-Chew RM, Islas-Romero R, García-García Mde L, Beeler JA, Audet S, Santos-Preciado JI, Gans H, Lew-Yasukawa L, Maldonado YA, Arvin AM, Valdespino-Gómez JL.

Vaccine. 2006 Jan 30;24(5):683-90. Epub 2005 Aug 24.

PMID:
16154241
17.
18.

Immunogenicity and reactogenicity of a single dose of live attenuated varicella vaccine and a booster dose of measles-mumps-rubella vaccine given concomitantly at 12 years of age.

Parment PA, Svahn A, Rudén U, Bråkenhielm G, Storsaeter J, Akesson L, Linde A.

Scand J Infect Dis. 2003;35(10):736-42.

PMID:
14606613
19.

The impact of maternal measles-rubella immunization on the 12-month-old infant's immune response to measles-mumps-rubella vaccine immunogenicity.

Saffar MJ, Ajami A, Khalilian AR, Saffar H.

Eur J Clin Microbiol Infect Dis. 2009 Jul;28(7):845-7. doi: 10.1007/s10096-009-0702-z. Epub 2009 Feb 20.

PMID:
19229565
20.

Immunogenicity and safety of two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children.

Knuf M, Habermehl P, Zepp F, Mannhardt W, Kuttnig M, Muttonen P, Prieler A, Maurer H, Bisanz H, Tornieporth N, Descamps D, Willems P.

Pediatr Infect Dis J. 2006 Jan;25(1):12-8.

PMID:
16395096

Supplemental Content

Support Center